Image-guided proton therapy for low- and intermediate-risk prostate cancer: Three-year results of two prospective trials.

被引：0
|
作者：
Henderson, Randal H.
Hoppe, Bradford S.
Nichols, Romaine Charles
Mendenhall, William M.
Marcus, Robert B.
Su, Zhong
Williams, Christopher R.
Li, Zuofeng
Morris, Christopher G.
Mendenhall, Nancy Price
机构：
[1] Univ Florida, Proton Therapy Inst, Jacksonville, FL USA
[2] Univ Florida, Coll Med, Dept Surg, Jacksonville, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.152
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
152
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Volumetric Modulated Arc Therapy Decreases Incidence of Acute Rectal Toxicity in the Treatment of Low- and Intermediate-Risk Prostate Cancer
    Dominello, M.
    Ku, K.
    Chen, G.
    Tait, L.
    Snyder, M.
    McSpadden, E.
    Maier, J.
    Miller, S.
    Konski, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S365 - S365
  • [32] Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Disease Control and Quality of Life at 8 Years
    Katz, A.
    Kang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E187 - E187
  • [33] Using NBN to predict biochemical relapse following image-guided radiotherapy (IGRT) for intermediate-risk prostate cancer (IR-PCa)
    Berlin, Alejandro
    Lalonde, Emilie
    Zafarana, Gaetano
    Sykes, Jenna
    Ramnarine, Varune Rohan
    Lam, Wan
    Meng, Alice
    Milosevic, Michael
    van der Kwast, Theodorus
    Boutros, Paul C.
    Bristow, Robert Glen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [34] Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer
    Bremer, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (02) : 192 - 193
  • [35] Phase I Dose-Escalation Study of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
    Boike, Thomas P.
    Lotan, Yair
    Cho, L. Chinsoo
    Brindle, Jeffrey
    DeRose, Paul
    Xie, Xian-Jin
    Yan, Jingsheng
    Foster, Ryan
    Pistenmaa, David
    Perkins, Alida
    Cooley, Susan
    Timmerman, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : 2020 - 2026
  • [36] A Prospective, Single-Arm, Phase II, Multi-Center Study of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
    Olson, A. C.
    Skiba, J. H.
    Gill, B. S.
    Wang, H.
    Davies, B.
    Holeva, K.
    D'Ambrosio, D.
    Wegner, R. E.
    Heron, D. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E288 - E289
  • [37] Prospective Evaluation of Stereotactic Body Radiation Therapy for Low- and Intermediate-risk Prostate Cancer: Emulating High-dose-rate Brachytherapy Dose Distribution
    Fuller, D. B.
    Mardirossian, G.
    Wong, D.
    Morris, D.
    Underhil, K.
    Medbery, C.
    Peddada, A.
    McKellar, H.
    Gray, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S149 - S149
  • [38] Five-year clinical outcomes after dose-escalated image-guided proton therapy for prostate cancer
    Bryant, C.
    Mendenhall, W.
    Hoppe, B.
    Henderson, R.
    Nichols, R.
    Morris, C.
    Williams, C.
    Su, Z.
    Li, Z.
    Mendenhall, N.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S114 - S114
  • [39] Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer
    Henderson, Randal H.
    Bryant, Curtis M.
    Nichols, R. Charles
    Mendenhall, William M.
    Hoppe, Bradford S.
    Su, Zhong
    Morris, Christopher G.
    Mendenhall, Nancy P.
    ACTA ONCOLOGICA, 2022, 61 (04) : 468 - 477
  • [40] Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
    Albers, Peter
    Wiegel, Thomas
    Schmidberger, Heinz
    Bussar-Maatz, Roswitha
    Haerter, Martin
    Kristiansen, Glen
    Martus, Peter
    Meisner, Christoph
    Wellek, Stefan
    Grozinger, Klaus
    Renner, Peter
    Burmester, Martin
    Schneider, Fried
    Stoeckle, Michael
    WORLD JOURNAL OF UROLOGY, 2021, 39 (01) : 65 - 72
12345